Alternative splicing: A new drug target of the post-genome era
- 1 December 2005
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
- Vol. 1754 (1-2) , 324-331
- https://doi.org/10.1016/j.bbapap.2005.09.010
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- National Institute of Biomedical Innovation
This publication has 71 references indexed in Scilit:
- ASF/SF2 and SC35 regulate the glutamate receptor subunit 2 alternative flip/flop splicingFEBS Letters, 2005
- Synthesis of selective SRPK-1 inhibitors: Novel tricyclic quinoxaline derivativesBioorganic & Medicinal Chemistry Letters, 2005
- Selective Inhibition of Topoisomerase I and Various Steps of Spliceosome Assembly by Diospyrin DerivativesMolecular Pharmacology, 2005
- Manipulation of Alternative Splicing by a Newly Developed Inhibitor of ClksJournal of Biological Chemistry, 2004
- De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma CellsJournal of Biological Chemistry, 2002
- Heterogeneous Ribonucleoprotein A1 Is Part of an Exon-specific Splice-silencing Complex Controlled by Oncogenic Signaling PathwaysPublished by Elsevier ,2000
- cdc2 Kinase-Mediated Phosphorylation of Splicing Factor SF2/ASFBiochemical and Biophysical Research Communications, 1998
- Novel SR-Protein-Specific Kinase, SRPK2, Disassembles Nuclear SpecklesBiochemical and Biophysical Research Communications, 1998
- A serine kinase regulates intracellular localization of splicing factors in the cell cycleNature, 1994
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993